Clinical Trials
12 trialsNCT06937177 2026-05-11
Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Colorectal Cancer Undergoing Chemotherapy
Endevica Bio
Phase 2 Recruiting
NCT07168226 2025-09-11
Phase 2 Cachexia Clinical Trial to Evaluate the Efficacy and Safety of ASCA101
MetaFines
Phase 2 Not yet recruiting
NCT05546476 2025-05-31
PROACC-1
Pfizer
Phase 2 Completed
NCT00866970 2020-07-09
Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia
CSL Behring
Phase 2 Completed
NCT01433263 2016-03-02
Clinical Study of BYM338 for the Treatment of Unintentional Weight Loss in Patients With Cancer of the Lung or the Pancreas
Novartis
Phase 2 Completed
NCT01238107 2014-09-10
A Clinical Study With MT-102 in Subjects With Cancer Cachexia
Akamis Bio
Phase 2 Completed
NCT00467844 2014-07-11
Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.
GTx
Phase 2 Completed
NCT00219817 2013-09-02
Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss
Helsinn Therapeutics (U.S.), Inc
Phase 2 Completed
NCT00527319 2013-01-30
VT-122
Vicus Therapeutics
Phase 2 Completed
NCT00895726 2012-01-13
Pilot Study of APD209 in Cancer Cachexia
Acacia Pharma Ltd
Phase 2 Completed
NCT00060502 2011-05-17
A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia
Centocor, Inc.
Phase 2 Completed
NCT00535015 2008-07-22
Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung Cancer
Anaborex
Phase 2 Terminated